Fidelity International’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-183,200
Closed -$9.22M 560
2013
Q3
$9.22M Buy
+183,200
New +$9.59M 0.04% 317

Other funds holding LLY

Fidelity International's LLY Position: Q1 2026 in Review

Fidelity International reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $6.46M and leaving 191,147 shares worth $176M. The position accounts for 0.14% of the portfolio, ranked #166.

Fidelity International first reported a position in LLY in Q2 2014 and has held it in 48 quarters since. The position peaked at $423M in Q1 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fidelity International held 191,147 shares of Eli Lilly worth $176M as of Q1 2026.
  • Fidelity International sold 6,374 Eli Lilly shares in Q1 2026, an estimated $6.46M.
  • Eli Lilly made up 0.14% of Fidelity International's portfolio in Q1 2026, its #166 holding.
  • Fidelity International first reported a position in Eli Lilly in Q2 2014 and has held it in 48 quarters since.
  • Fidelity International's Eli Lilly position peaked at $423M in Q1 2015.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.